Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Topical Corticosteroids Market Forecast Highlighting Growth From $9.88 Billion To $13.13 Billion
The topical corticosteroids market has experienced robust expansion in recent years. It is projected to increase from $9.17 billion in 2025 to $9.88 billion in 2026, with a compound annual growth rate (CAGR) of 7.7%. Historical growth has been fueled by the rising prevalence of eczema and dermatitis, a growing number of dermatology clinic consultations, the extensive use of prescription topical steroids, heightened public awareness regarding skin health, and the broadening of hospital pharmacy distribution networks.
The topical corticosteroids market is anticipated to experience significant expansion over the next several years. By 2030, it is projected to reach a value of $13.13 billion, with a compound annual growth rate (CAGR) of 7.4%. Factors driving this growth during the forecast period include the creation of innovative formulations with fewer side effects, the expansion of over-the-counter hydrocortisone products, a greater reliance on internet-based pharmacies, a growing need for customized dermatological treatments, and the wider implementation of at-home skincare solutions. Key developments shaping the market in the coming years include the increasing occurrence of persistent skin conditions, heightened demand for non-prescription corticosteroid items, more frequent application of combined topical treatments, the widening reach of online and physical pharmacy outlets, and a stronger emphasis on safer, low-potency products suitable for extended use.
Download A Free Sample Report For Comprehensive Market Insights:
Topical Corticosteroids Market Expansion Drivers: What Is Shaping Future Growth?
The upward trend in skin disorder cases is set to boost the topical corticosteroids market moving ahead. Skin disorders encompass various conditions that alter the skin’s look, structure, or function, often compromising overall health, comfort, and life quality. This increase in skin disorders stems from heightened stress linked to modern lifestyles—marked by extended work hours, unhealthy eating habits, and prolonged screen time—which damages skin health and pushes people to pursue effective skincare and dermatological treatments. Topical corticosteroids are crucial for managing these disorders as they alleviate inflammation, itching, and redness by dampening excessive immune responses, making them vital for handling issues like eczema, psoriasis, and dermatitis. As an illustration, Cancer Australia, an Australian government agency, reported in September 2024 that an estimated 18,257 new melanoma cases were diagnosed in 2023, with 1,314 deaths that year. Consequently, the growing prevalence of skin disorders is fueling expansion in the topical corticosteroids market.
Topical Corticosteroids Market Segmentation Trends And Revenue Drivers
The topical corticosteroids market covered in this report is segmented –
1) By Type: Prescription, Over-The-Counter (OTC)
2) By Medication Type: Ointments, Creams, Liquid And Solutions, Lotions, Gel, Oils, Pastes, Sprays, Other Medication Types
3) By Distribution Channel: Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Other Distribution Channels
4) By Application: Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Other Applications
5) By End User: Hospital, Dermatology Clinics, Homecare, Other End Users
Subsegments:
1) By Prescription: Potent, Moderate Potency Topical Corticosteroids, Mild Topical Corticosteroids, Prescription Combination Products
2) By Over-The-Counter: Hydrocortisone Creams And Ointments, OTC Combination Creams, Corticosteroid Sprays, Corticosteroid Lotions And Gels
Topical Corticosteroids Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Leading players in the topical corticosteroids market are placing greater emphasis on nanoparticle-based corticosteroid formulations to address the increasing demand for safer, more reliable, and more effective anti-inflammatory therapies after surgery. A nanoparticle-based corticosteroid formulation functions as a drug delivery method in which corticosteroids are encapsulated within tiny nanoparticles to enhance skin absorption, enable controlled drug release, and minimize systemic side effects. For example, in September 2024, Eyenovia, an ophthalmic pharmaceutical firm based in the US, introduced clobetasol propionate ophthalmic suspension 0.05%, an advanced corticosteroid developed using Formosa Pharmaceuticals’ APNT nanoparticle technology. This product offers a stable nanosuspension that stays uniform throughout the bottle, supports twice-daily application, and delivers rapid relief from pain and inflammation after ocular surgery, with clinical evidence indicating that complete pain resolution occurs in around 80% of patients by day 4. Its preparation lowers the likelihood of adverse effects and makes it the first new ophthalmic steroid to become available in the US market in over 15 years, thereby enhancing both patient experience and treatment results.
Topical Corticosteroids Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the topical corticosteroids market are Merck & Co. Inc., GSK plc , Teva Pharmaceutical Industries Ltd., Sandoz International GmbH , Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Menarini Group, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited , LEO Pharma A/S, Taro Pharmaceutical Industries Ltd., Ajanta Pharma Ltd., Micro Labs Ltd., FDC Limited, Harrow Inc., Salve Pharmaceuticals Pvt. Ltd., Lincoln Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd.
Access The Complete Topical Corticosteroids Market Report:
Topical Corticosteroids Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the topical corticosteroids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model